Marex Group’s Advent Technologies ADN Stock Holding History

Marex Group’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$3.34K	–	488
2023 Q4	$3.34K	Buy	+500	New	+$5.76K	﹤0.01%	554

Other funds holding ADN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Marex Group's ADN Position: Q1 2024 in Review

Marex Group sold out of Advent Technologies (ADN) in Q1 2024, closing a stake of 500 shares — an estimated $3.34K sold.

Marex Group first reported a position in ADN in Q4 2023 and held it in 1 quarter. The position peaked at $3.34K in Q4 2023. 32 funds tracked by Wall St. Rank hold ADN as of Q1 2024.

Marex Group reported no remaining Advent Technologies position as of Q1 2024 after selling out during the quarter.
Marex Group sold 500 Advent Technologies shares in Q1 2024, an estimated $3.34K.
Marex Group first reported a position in Advent Technologies in Q4 2023 and held it in 1 quarter.
Marex Group's Advent Technologies position peaked at $3.34K in Q4 2023.
32 funds tracked by Wall St. Rank held Advent Technologies as of Q1 2024.

Based on Marex Group's 13F filing for Q1 2024, filed 2 Apr 2026.